共 278 条
[1]
Weinstock MA(2009)Quality of life in the actinic neoplasia syndrome: the VA topical tretinoin chemoprevention (VATTC) trial J Am Acad Dermatol 61 207-215
[2]
Lee KC(2010)Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model Pharmacoeconomics. 28 1055-1064
[3]
Chren MM(2012)Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group J Eur Acad Dermatol Venereol 26 48-53
[4]
Marcolivio K(2008)Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey Dermatology 216 194-199
[5]
Wilson EC(2009)Pharmacoeconomic considerations in treating actinic keratosis Pharmacoeconomics. 27 451-464
[6]
Pflugfelder A(2010)Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer J Clin Aesthet Dermatol. 3 39-44
[7]
Welter AK(2014)Cost for the treatment of actinic keratosis on the rise in Australia. Version 2 F1000Res 3 184-653
[8]
Leiter U(2014)Basalioomat, okasolusyöpä ja sen esiasteet, miten hoidan? [Basal cell carcinoma, squamous cell carcinoma and premalignant skin lesions—how to treat?] Duodecim. 130 643-1039
[9]
Bernard P(1998)The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia) Br J Dermatol 139 1033-1159
[10]
Dupuy A(2000)Prevalence of solar damage and actinic keratosis in a Merseyside population Br J Dermatol 142 1154-7